Stock Spotlight Archives

FridayAug 07, 2026 2:55 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory and commercial milestones amid growing interest in regenerative orthopedic solutions. GelrinC is an off-the-shelf, cell-free implant designed for a streamlined, single-step procedure that supports cartilage regeneration without the cell harvesting and laboratory processing required by some alternative approaches. Regentis is continuing enrollment in its U.S. clinical study, preparing for a potential FDA Premarket Approval submission, expanding commercialization efforts in Europe following CE Mark approval, and optimizing manufacturing for scalability and consistency. To view the full article, visit https://ibn.fm/mVCsB About Regentis Biomaterials Ltd. Regentis Biomaterials is a…

FridayAug 07, 2026 2:12 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approach to Neurological Health

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on advancing innovative therapies and technologies, is developing a two-pronged strategy addressing neurological health through its investigational multiple sclerosis therapy Lucid-MS and its proprietary dietary supplement unbuzzd. Lucid-MS is designed to target PAD2, an enzyme associated with myelin degradation, with the goal of protecting and potentially restoring the myelin sheath rather than primarily modulating the immune system. The company submitted an IND application to the FDA for a Phase 2 trial and is supporting development through an imaging collaboration…

FridayAug 07, 2026 1:04 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Builds Strategic Position in Antibody Therapeutics Market

VERAXA Biotech (NASDAQ: VRXA) is developing next-generation antibody therapeutics across antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), two areas that continue to attract significant pharmaceutical investment. A recent article highlights major transactions to illustrate how differentiated antibody-engineering platforms can attract substantial financial commitments even before clinical development reaches advanced stages. VERAXA’s proprietary BiTAC platform supports a pipeline that includes bispecific ADCs, T-cell engagers and engineered antibody formats, potentially creating opportunities for future platform partnerships, licensing agreements or asset-level transactions. To view the full article, visit https://ibn.fm/sMjlp About VERAXA Biotech AG VERAXA is building a premier engine for the discovery and development of…

WednesdayAug 05, 2026 1:54 pm

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Expands Project Holdings in Prolific Abitibi Belt

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) was featured in a recent article that discussed its efforts to expand its gold project holdings in Québec’s prolific Abitibi Greenstone Belt through the acquisition of 27 mineral claims totaling approximately 701 hectares adjacent to its McKenzie East Project. The transaction increases LaFleur’s overall Abitibi land position to more than 23,100 hectares across 490 claims and adds ground containing a historical Maruska gold showing, which the company plans to explore through data compilation, drilling and other exploration activities. Meanwhile, LaFleur is…

WednesdayAug 05, 2026 1:15 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Combines Targeted Cancer Therapy, Nanotechnology and AI

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is pursuing an integrated approach to cancer drug development that combines three emerging areas: PNKP-targeted DNA damage response (“DDR”) inhibition, nanoparticle drug delivery and artificial intelligence. Its lead candidate, ONC010, pairs a PNKP inhibitor with a polymer micelle carrier intended to improve drug solubility, tumor accumulation and tolerability, while the company’s Inka Health subsidiary is developing the SynoGraph causal AI platform to support patient selection, clinical trial design and evidence generation. The company is advancing ONC010 through preclinical, manufacturing and IND-enabling…

WednesdayAug 05, 2026 12:52 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Advances Telehealth Position Through Technology, Vertical Integration

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its positioning in the growing telehealth and healthcare markets through strategic investments, vertical integration and proprietary technology. Through subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc., the company provides online and brick-and-mortar telehealth services focused on wellness and direct-to-patient delivery, while also targeting the expanding peptide therapy market. ETST’s in-house IT capabilities and custom technology infrastructure are designed to provide a competitive advantage by improving operational efficiency and margins across its divisions. As the company continues expanding its technology and healthcare offerings, its integrated platform…

WednesdayAug 05, 2026 12:28 pm

QualityStocksNewsBreaks – Why BOXABL Inc. (NASDAQ: BXBL) Is ‘One to Watch’

BOXABL (NASDAQ: BXBL) was featured in a recent article that discussed its positioning as a technology company focused on transforming residential construction through a factory-built, modular housing system designed for scale. The publication reads, “By shifting homebuilding from traditional on-site processes to controlled manufacturing environments, the company aims to introduce a more standardized, efficient and repeatable approach to housing production. Its model integrates design, engineering and manufacturing into a unified system intended to improve speed, cost predictability and overall accessibility.” To view the full article, visit https://ibn.fm/7u9QR About BOXABL Inc. BOXABL is transforming the housing market with its modular building systems designed to…

MondayAug 03, 2026 2:44 pm

QualityStocksNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Deepens AI Integration Across Digital Platform

Beeline Holdings (NASDAQ: BLNE) was featured in an article that discussed its recent acquisition of artificial intelligence company MagicBlocks, bringing in-house the technology that already powers key components of its mortgage platform. The move gives the digital platform greater control over AI development across mortgage origination, title services, home equity products and future digital real estate transactions. Beeline’s AI-powered customer assistant Bob has already demonstrated measurable results, with Beeline reporting an 8% increase in lead-to-lock mortgage conversions among customers who engage with the assistant during the application process. The company says the acquisition is expected to accelerate AI deployment and improve…

MondayAug 03, 2026 2:08 pm

QualityStocksNewsBreaks – Rare Earth Supply Gap Creates Opportunity for Junior Developers Like Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) was featured in a recent article that discussed the company’s efforts to advance a diversified portfolio of rare earth and uranium assets across Brazil, the United States and Canada as global demand for rare earth elements continues to rise and Western governments seek to reduce supply-chain dependence on China. The global rare earth elements market is projected to grow from approximately $14 billion in 2025 to more than $41 billion by 2034, fueled by demand from electric vehicles, wind…

FridayJul 31, 2026 3:07 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed its efforts to advance GelrinC, a potentially first-in-class, off-the-shelf cartilage regeneration platform, and the company’s broader mission to establish a new standard of care in cartilage repair. “Regentis is developing regenerative biomaterial technology as healthcare shifts toward therapies designed to restore damaged tissue rather than simply manage symptoms. With cartilage defects affecting hundreds of thousands of patients each year and contributing to pain, reduced mobility, and degenerative joint disease, the company is targeting one of orthopedic medicine’s largest unmet needs,” reads the article. “GelrinC’s commercial potential is rooted in…

Site Search

Company Search

Category: Stock Spotlight